2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of …
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and can complicate the majority of cardiovascular and respiratory …
clinical conditions and can complicate the majority of cardiovascular and respiratory …
Six-minute walk test: clinical role, technique, coding, and reimbursement
P Agarwala, SH Salzman - Chest, 2020 - Elsevier
The 6-min walk test (6MWT) is a commonly used test for the objective assessment of
functional exercise capacity for the management of patients with moderate-to-severe …
functional exercise capacity for the management of patients with moderate-to-severe …
[PDF][PDF] 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
6.2. 2. Wydolność wysiłkowa......................... 1147 6.2. 3. Markery biochemiczne........................
1147 6.2. 4. Kompleksowa ocena rokownicza i oszacowanie ryzyka........................... 1148 6.2 …
1147 6.2. 4. Kompleksowa ocena rokownicza i oszacowanie ryzyka........................... 1148 6.2 …
A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension
D Kylhammar, B Kjellström, C Hjalmarsson… - European heart …, 2018 - academic.oup.com
Aims Guidelines recommend a goal-oriented treatment approach in pulmonary arterial
hypertension (PAH). The aim is to reach a low-risk profile, as determined by a risk …
hypertension (PAH). The aim is to reach a low-risk profile, as determined by a risk …
Riociguat for the treatment of chronic thromboembolic pulmonary hypertension
HA Ghofrani, AM D'Armini, F Grimminger… - … England Journal of …, 2013 - Mass Medical Soc
Background Riociguat, a member of a new class of compounds (soluble guanylate cyclase
stimulators), has been shown in previous clinical studies to be beneficial in the treatment of …
stimulators), has been shown in previous clinical studies to be beneficial in the treatment of …
Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era
M Humbert, O Sitbon, A Chaouat, M Bertocchi… - Circulation, 2010 - Am Heart Assoc
Background—Novel therapies have recently become available for pulmonary arterial
hypertension. We conducted a study to characterize mortality in a multicenter prospective …
hypertension. We conducted a study to characterize mortality in a multicenter prospective …
Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy
MC van de Veerdonk, T Kind, JT Marcus… - Journal of the American …, 2011 - jacc.org
Objectives: The purpose of this study was to examine the relationship between changes in
pulmonary vascular resistance (PVR) and right ventricular ejection fraction (RVEF) and …
pulmonary vascular resistance (PVR) and right ventricular ejection fraction (RVEF) and …
ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation task force on expert consensus …
Writing Committee Members, VV McLaughlin… - Circulation, 2009 - Am Heart Assoc
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension | Circulation Science
Volunteer Warning signs SearchSearch Advanced Search Donate Circulation logo Hello Guest …
Volunteer Warning signs SearchSearch Advanced Search Donate Circulation logo Hello Guest …
Diagnosis and assessment of pulmonary arterial hypertension
DB Badesch, HC Champion… - Journal of the American …, 2009 - jacc.org
The diagnosis and assessment of pulmonary arterial hypertension is a rapidly evolving area,
with changes occurring in the definition of the disease, screening and diagnostic techniques …
with changes occurring in the definition of the disease, screening and diagnostic techniques …